CHIMERIC THERAPEUTICS LIMITED - Announcements

0.00%

13.5¢

Market Cap $5.965M

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company,... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company, focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its diversified portfolio includes first-in-class autologous CAR T cell therapies and allogeneic natural killer (NK) cell therapies. Its assets are being developed across multiple different disease areas in oncology with four clinical stage programs. Its pipeline includes CHM CDH17, CHM CLTX and CHM CORE NK platform. CHM CDH17 is a third-generation CDH17 CAR T, which is in phase I/II clinical trial in gastrointestinal and neuroendocrine tumors. CHM CORE-NK is a clinically validated NK cell platform in phase IB clinical trials investigating CORE-NK in combination regimens. CHM CLTX is a novel CAR-T therapy developed for the treatment of patients with solid tumors. CLTX CAR T is in phase IB clinical trial in recurrent/progressive glioblastoma. It is also building a Cell therapy portfolio.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

CHM	Proposed issue of securities - CHM		08/05/26	14.82KB	Share
CHM	Notification of cessation of securities - CHM		05/05/26	12.89KB	Share
CHM	Change in substantial holding		05/05/26	381.28KB	Share
CHM	Notification regarding unquoted securities - CHM		04/05/26	14.69KB	Share
CHM	Notice under section 708A		04/05/26	189.63KB	Share
CHM	Application for quotation of securities - CHM		04/05/26	15.92KB	Share
CHM	Application for quotation of securities - CHM		01/05/26	15.78KB	Share
CHM	Notification regarding unquoted securities - CHM		30/04/26	17.22KB	Share
CHM	Notification regarding unquoted securities - CHM		30/04/26	26.64KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/04/26	1.11MB	Share
CHM	Capital Consolidation Complete		29/04/26	199.89KB	Share
CHM	Update - Consolidation/Split - CHM		29/04/26	17.85KB	Share
CHM	CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi	PRICE SENSITIVE	27/04/26	204.85KB	Share
CHM	Update - Consolidation/Split - CHM		17/04/26	17.76KB	Share
CHM	Results of Meeting		17/04/26	323.53KB	Share
CHM	Notification of cessation of securities - CHM		09/04/26	12.8KB	Share
CHM	Investor presentation		25/03/26	3.08MB	Share
CHM	Chimeric to present at NWR Virtual Healthcare Conference		23/03/26	189.47KB	Share
CHM	Prospectus		23/03/26	536.01KB	Share
CHM	Update - Proposed issue of securities - CHM		19/03/26	16.91KB	Share
CHM	Consolidation/Split - CHM	PRICE SENSITIVE	19/03/26	17.5KB	Share
CHM	Notice of Extraordinary General Meeting/Proxy Form		19/03/26	1.07MB	Share
CHM	Letter to Shareholders		06/03/26	317.99KB	Share
CHM	Chimeric receives $1.8 M advance on FY26 R&D tax incentive	PRICE SENSITIVE	02/03/26	240.85KB	Share
CHM	Half Year Report and Appendix 4D 31 December 2025	PRICE SENSITIVE	27/02/26	3.79MB	Share
CHM	Portfolio streamlined - return of CHM CLTX to City of Hope	PRICE SENSITIVE	27/02/26	349.56KB	Share
CHM	Revised response to ASX Query Letter		25/02/26	1.61MB	Share
CHM	Proposed issue of securities - CHM		25/02/26	16.62KB	Share
CHM	Update - Proposed issue of securities - CHM		25/02/26	28.12KB	Share
CHM	Funding and EGM update	PRICE SENSITIVE	25/02/26	290.94KB	Share
CHM	Initial Director's Interest Notice (BG)		16/02/26	240.54KB	Share
CHM	Board and management update		16/02/26	209.45KB	Share
CHM	CHM CDH17 advances to Dose Level 3		12/02/26	190.61KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/01/26	915.34KB	Share
CHM	Change in substantial holding		09/01/26	226.21KB	Share
CHM	Notice under section 708A		07/01/26	273.45KB	Share
CHM	Application for quotation of securities - CHM		07/01/26	15.61KB	Share
CHM	Ceasing to be a substantial holder		05/01/26	256.97KB	Share
CHM	Notice under section 708A		31/12/25	282.78KB	Share
CHM	Application for quotation of securities - CHM		31/12/25	15.76KB	Share
CHM	Proposed issue of securities - CHM		23/12/25	27.88KB	Share
CHM	Proposed issue of securities - CHM		23/12/25	15.79KB	Share
CHM	$8.4 M funding to drive CHM CDH17 and resignation of CMO	PRICE SENSITIVE	23/12/25	287.28KB	Share
CHM	Notification regarding unquoted securities - CHM		19/12/25	16.24KB	Share
CHM	Change of Director's Interest Notice - MP		19/12/25	183KB	Share
CHM	Trading Halt	PRICE SENSITIVE	19/12/25	205.77KB	Share
CHM	CDH17 granted FDA Orphan Drug Designation for Gastric Cancer	PRICE SENSITIVE	08/12/25	200.87KB	Share
CHM	Company update-board changes, shareholder feedback & support		28/11/25	188.96KB	Share
CHM	Final Director's Interest Notice - PH		26/11/25	682.54KB	Share
CHM	Results of Meeting		25/11/25	230.84KB	Share
CHM	Presentation to AGM		25/11/25	2.24MB	Share
CHM	CHIMERIC RECEIVES $4.5M R&D TAX INCENTIVE	PRICE SENSITIVE	24/11/25	691.04KB	Share
CHM	75% disease control observed in CHM CDH17 trial	PRICE SENSITIVE	13/11/25	323.34KB	Share
CHM	CHM CORE NK Combination Phase 1b trial update	PRICE SENSITIVE	13/11/25	209.16KB	Share
CHM	Pause in Trading	PRICE SENSITIVE	13/11/25	113.39KB	Share
CHM	Response to ASX Query Letter	PRICE SENSITIVE	06/11/25	1.69MB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/25	1.3MB	Share
CHM	Notice of Annual General Meeting/Proxy Form		27/10/25	868.4KB	Share
CHM	Becoming a substantial holder		10/10/25	61.76KB	Share
CHM	Notification regarding unquoted securities - CHM		10/10/25	19.41KB	Share
CHM	Application for quotation of securities - CHM		10/10/25	15.94KB	Share
CHM	Presentation to investor webinar		08/10/25	3.52MB	Share
CHM	Investor update webinar - 11am AEDT, Wednesday 8 Oct		03/10/25	555.52KB	Share
CHM	Additional complete responses in CHM CORE-NK Phase 1b trial	PRICE SENSITIVE	02/10/25	651.23KB	Share
CHM	Disease control and tumour shrinkage observed in CHM CDH17	PRICE SENSITIVE	29/09/25	325.41KB	Share
CHM	Presentation to investor webinar		09/09/25	3.36MB	Share
CHM	Corporate Governance Statement and Appendix 4G		29/08/25	872.02KB	Share
CHM	Appendix 4E and Annual Report	PRICE SENSITIVE	29/08/25	6.48MB	Share
CHM	Webinar - CHM CDH17 deep dive with Professor Jennifer Eads		26/08/25	183.1KB	Share
CHM	Change of Director's Interest Notice MP		21/08/25	197.05KB	Share
CHM	Notification regarding unquoted securities - CHM		07/08/25	14.81KB	Share
CHM	Application for quotation of securities - CHM		07/08/25	15.98KB	Share
CHM	CHM CDH17 Clinical Trial Update	PRICE SENSITIVE	04/08/25	294.92KB	Share
CHM	Change in substantial holding - PH		29/07/25	121.63KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/07/25	1.24MB	Share
CHM	Proposed issue of securities - CHM		28/07/25	14.83KB	Share
CHM	Notification regarding unquoted securities - CHM		25/07/25	18.25KB	Share
CHM	Application for quotation of securities - CHM		25/07/25	15.93KB	Share
CHM	Notification regarding unquoted securities - CHM		25/07/25	18.33KB	Share
CHM	Application for quotation of securities - CHM		25/07/25	15.92KB	Share
CHM	Update - Proposed issue of securities - CHM		24/07/25	26.06KB	Share
CHM	Proposed issue of securities - CHM		23/07/25	23.43KB	Share
CHM	Prospectus		23/07/25	556.44KB	Share
CHM	Results of Meeting		23/07/25	165.96KB	Share
CHM	Presentation to Extraordinary General Meeting		23/07/25	2.34MB	Share
CHM	Initial Director's Interest Notice		02/07/25	241.53KB	Share
CHM	Change of Director's Interest Notice LR		01/07/25	103.41KB	Share
CHM	Professor Miles Prince appointed as Non-Executive Director		01/07/25	181.68KB	Share
CHM	Notification of cessation of securities - CHM		26/06/25	13.44KB	Share
CHM	Notice of Extraordinary General Meeting/Proxy Form		24/06/25	1.04MB	Share
CHM	Translational data shows persistence of CHM CDH17		17/06/25	277.09KB	Share
CHM	Chimeric receives $2.5 M advance on FY25 R&D tax incentive	PRICE SENSITIVE	10/06/25	188.91KB	Share
CHM	CHM CDH17 receives FDA Fast Track	PRICE SENSITIVE	04/06/25	196.96KB	Share
CHM	Application for quotation of securities - CHM		29/05/25	15.5KB	Share
CHM	Change in substantial holding - PH		28/05/25	122.14KB	Share
CHM	Application for quotation of securities - CHM		26/05/25	15.64KB	Share
CHM	Letter to Shareholders		26/05/25	206.15KB	Share
CHM	Prospectus		26/05/25	428.54KB	Share
CHM	Presentation to investor webinar		22/05/25	1.84MB	Share
CHM	CHM CDH17 ADVANCES TO DOSE LEVEL 2	PRICE SENSITIVE	21/05/25	296.35KB	Share

CHM Proposed issue of securities - CHM
08/05/26		14.82KB	Share
CHM Notification of cessation of securities - CHM
05/05/26		12.89KB	Share
CHM Change in substantial holding
05/05/26		381.28KB	Share
CHM Notification regarding unquoted securities - CHM
04/05/26		14.69KB	Share
CHM Notice under section 708A
04/05/26		189.63KB	Share
CHM Application for quotation of securities - CHM
04/05/26		15.92KB	Share
CHM Application for quotation of securities - CHM
01/05/26		15.78KB	Share
CHM Notification regarding unquoted securities - CHM
30/04/26		17.22KB	Share
CHM Notification regarding unquoted securities - CHM
30/04/26		26.64KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
29/04/26	PRICE SENSITIVE	1.11MB	Share
CHM Capital Consolidation Complete
29/04/26		199.89KB	Share
CHM Update - Consolidation/Split - CHM
29/04/26		17.85KB	Share
CHM CHM CORE-NK Phase 1B clinical trial achieves 60% CR/CRi
27/04/26	PRICE SENSITIVE	204.85KB	Share
CHM Update - Consolidation/Split - CHM
17/04/26		17.76KB	Share
CHM Results of Meeting
17/04/26		323.53KB	Share
CHM Notification of cessation of securities - CHM
09/04/26		12.8KB	Share
CHM Investor presentation
25/03/26		3.08MB	Share
CHM Chimeric to present at NWR Virtual Healthcare Conference
23/03/26		189.47KB	Share
CHM Prospectus
23/03/26		536.01KB	Share
CHM Update - Proposed issue of securities - CHM
19/03/26		16.91KB	Share
CHM Consolidation/Split - CHM
19/03/26	PRICE SENSITIVE	17.5KB	Share
CHM Notice of Extraordinary General Meeting/Proxy Form
19/03/26		1.07MB	Share
CHM Letter to Shareholders
06/03/26		317.99KB	Share
CHM Chimeric receives $1.8 M advance on FY26 R&D tax incentive
02/03/26	PRICE SENSITIVE	240.85KB	Share
CHM Half Year Report and Appendix 4D 31 December 2025
27/02/26	PRICE SENSITIVE	3.79MB	Share
CHM Portfolio streamlined - return of CHM CLTX to City of Hope
27/02/26	PRICE SENSITIVE	349.56KB	Share
CHM Revised response to ASX Query Letter
25/02/26		1.61MB	Share
CHM Proposed issue of securities - CHM
25/02/26		16.62KB	Share
CHM Update - Proposed issue of securities - CHM
25/02/26		28.12KB	Share
CHM Funding and EGM update
25/02/26	PRICE SENSITIVE	290.94KB	Share
CHM Initial Director's Interest Notice (BG)
16/02/26		240.54KB	Share
CHM Board and management update
16/02/26		209.45KB	Share
CHM CHM CDH17 advances to Dose Level 3
12/02/26		190.61KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
28/01/26	PRICE SENSITIVE	915.34KB	Share
CHM Change in substantial holding
09/01/26		226.21KB	Share
CHM Notice under section 708A
07/01/26		273.45KB	Share
CHM Application for quotation of securities - CHM
07/01/26		15.61KB	Share
CHM Ceasing to be a substantial holder
05/01/26		256.97KB	Share
CHM Notice under section 708A
31/12/25		282.78KB	Share
CHM Application for quotation of securities - CHM
31/12/25		15.76KB	Share
CHM Proposed issue of securities - CHM
23/12/25		27.88KB	Share
CHM Proposed issue of securities - CHM
23/12/25		15.79KB	Share
CHM $8.4 M funding to drive CHM CDH17 and resignation of CMO
23/12/25	PRICE SENSITIVE	287.28KB	Share
CHM Notification regarding unquoted securities - CHM
19/12/25		16.24KB	Share
CHM Change of Director's Interest Notice - MP
19/12/25		183KB	Share
CHM Trading Halt
19/12/25	PRICE SENSITIVE	205.77KB	Share
CHM CDH17 granted FDA Orphan Drug Designation for Gastric Cancer
08/12/25	PRICE SENSITIVE	200.87KB	Share
CHM Company update-board changes, shareholder feedback & support
28/11/25		188.96KB	Share
CHM Final Director's Interest Notice - PH
26/11/25		682.54KB	Share
CHM Results of Meeting
25/11/25		230.84KB	Share
CHM Presentation to AGM
25/11/25		2.24MB	Share
CHM CHIMERIC RECEIVES $4.5M R&D TAX INCENTIVE
24/11/25	PRICE SENSITIVE	691.04KB	Share
CHM 75% disease control observed in CHM CDH17 trial
13/11/25	PRICE SENSITIVE	323.34KB	Share
CHM CHM CORE NK Combination Phase 1b trial update
13/11/25	PRICE SENSITIVE	209.16KB	Share
CHM Pause in Trading
13/11/25	PRICE SENSITIVE	113.39KB	Share
CHM Response to ASX Query Letter
06/11/25	PRICE SENSITIVE	1.69MB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/10/25	PRICE SENSITIVE	1.3MB	Share
CHM Notice of Annual General Meeting/Proxy Form
27/10/25		868.4KB	Share
CHM Becoming a substantial holder
10/10/25		61.76KB	Share
CHM Notification regarding unquoted securities - CHM
10/10/25		19.41KB	Share
CHM Application for quotation of securities - CHM
10/10/25		15.94KB	Share
CHM Presentation to investor webinar
08/10/25		3.52MB	Share
CHM Investor update webinar - 11am AEDT, Wednesday 8 Oct
03/10/25		555.52KB	Share
CHM Additional complete responses in CHM CORE-NK Phase 1b trial
02/10/25	PRICE SENSITIVE	651.23KB	Share
CHM Disease control and tumour shrinkage observed in CHM CDH17
29/09/25	PRICE SENSITIVE	325.41KB	Share
CHM Presentation to investor webinar
09/09/25		3.36MB	Share
CHM Corporate Governance Statement and Appendix 4G
29/08/25		872.02KB	Share
CHM Appendix 4E and Annual Report
29/08/25	PRICE SENSITIVE	6.48MB	Share
CHM Webinar - CHM CDH17 deep dive with Professor Jennifer Eads
26/08/25		183.1KB	Share
CHM Change of Director's Interest Notice MP
21/08/25		197.05KB	Share
CHM Notification regarding unquoted securities - CHM
07/08/25		14.81KB	Share
CHM Application for quotation of securities - CHM
07/08/25		15.98KB	Share
CHM CHM CDH17 Clinical Trial Update
04/08/25	PRICE SENSITIVE	294.92KB	Share
CHM Change in substantial holding - PH
29/07/25		121.63KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
29/07/25	PRICE SENSITIVE	1.24MB	Share
CHM Proposed issue of securities - CHM
28/07/25		14.83KB	Share
CHM Notification regarding unquoted securities - CHM
25/07/25		18.25KB	Share
CHM Application for quotation of securities - CHM
25/07/25		15.93KB	Share
CHM Notification regarding unquoted securities - CHM
25/07/25		18.33KB	Share
CHM Application for quotation of securities - CHM
25/07/25		15.92KB	Share
CHM Update - Proposed issue of securities - CHM
24/07/25		26.06KB	Share
CHM Proposed issue of securities - CHM
23/07/25		23.43KB	Share
CHM Prospectus
23/07/25		556.44KB	Share
CHM Results of Meeting
23/07/25		165.96KB	Share
CHM Presentation to Extraordinary General Meeting
23/07/25		2.34MB	Share
CHM Initial Director's Interest Notice
02/07/25		241.53KB	Share
CHM Change of Director's Interest Notice LR
01/07/25		103.41KB	Share
CHM Professor Miles Prince appointed as Non-Executive Director
01/07/25		181.68KB	Share
CHM Notification of cessation of securities - CHM
26/06/25		13.44KB	Share
CHM Notice of Extraordinary General Meeting/Proxy Form
24/06/25		1.04MB	Share
CHM Translational data shows persistence of CHM CDH17
17/06/25		277.09KB	Share
CHM Chimeric receives $2.5 M advance on FY25 R&D tax incentive
10/06/25	PRICE SENSITIVE	188.91KB	Share
CHM CHM CDH17 receives FDA Fast Track
04/06/25	PRICE SENSITIVE	196.96KB	Share
CHM Application for quotation of securities - CHM
29/05/25		15.5KB	Share
CHM Change in substantial holding - PH
28/05/25		122.14KB	Share
CHM Application for quotation of securities - CHM
26/05/25		15.64KB	Share
CHM Letter to Shareholders
26/05/25		206.15KB	Share
CHM Prospectus
26/05/25		428.54KB	Share
CHM Presentation to investor webinar
22/05/25		1.84MB	Share
CHM CHM CDH17 ADVANCES TO DOSE LEVEL 2
21/05/25	PRICE SENSITIVE	296.35KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.


Last 13.5¢		Change 0.000(0.00%)		Mkt cap ! $5.965M

Open	High	Low	Volume
15.5¢	15.5¢	13.0¢	144.6K

Buyers (Bids)

Vol.	Price($)
69566	13.5¢

Sellers (Offers)

Price($)	Vol.
14.5¢	50000

Last trade - 16.10pm 11/05/2026 (20 minute delay)

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available